Dividend Stocks: IOC, Hindalco, MCX, Mankind Pharma and More Turning Ex-Dividend Today, August 8, 2025

Today, August 8, several well-known companies will trade ex-dividend. These include Indian Oil Corporation (IOC), Hindalco Industries, Mankind Pharma, ABB India, Multi Commodity Exchange (MCX), and Alkem Laboratories. Nestle India will also turn ex-bonus on the same day.

Dividend Payout Details

• IOC: Final dividend of ₹3 per share (face value ₹10), record date August 8. Payment within 30 days if approved.
• Hindalco Industries: Final dividend of ₹5 per share (face value ₹1), record date August 8.
• Mankind Pharma: Interim dividend of ₹1 per share (face value ₹1), record date August 8. Payment within 30 days if approved.
• MCX: Final dividend of ₹30 per share (face value ₹10), record date August 8.

Other Companies Turning Ex-Dividend

Many other firms will also trade ex-dividend on August 8, including:

• Aurobindo Pharma – ₹4 per share
• Alkem Laboratories – ₹8 per share
• Ceat – ₹30 per share
• ZF Commercial Vehicle Control Systems India – ₹19 per share
• Sonata Software – ₹1.25 per share
• Quess Corp – ₹6 per share
• Delta Corp – ₹1.25 per share
• Paras Defence & Space Technologies – ₹0.5 per share

Upcoming Earnings Announcements

Today, August 8, major companies like SBI, Tata Motors, Voltas, Grasim Industries, Info Edge, and Siemens will announce their Q1 FY26 results.

Also Read: Upcoming Dividends in August 2025!

Market Recap for August 7

On Thursday, August 7, Indian markets rebounded after two days of losses. The Sensex surged 811 points from the day’s low to close at 80,623.26, up 0.10%. The Nifty50 rose 21.95 points to end at 24,596.15.

Conclusion

August 8 is an important day for investors with multiple stocks turning ex-dividend and several major companies reporting earnings. Investors should track these dates closely to manage dividend eligibility and market moves.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.